Factory 98% Oroxylin a Powder CAS 480-11-5 Anti-Cancer Oroxylin a

• Customization: Available
• Certification: RoHS, BRC, ISO, FDA, HACCP
• Assay Method: HPLC-MS, GPC, HPLC, UV
• Model NO.: C11
• Application Form: Injection, Lotion, Suppository, Paste, Tablet, Capsule
• Application: Food, Health Care Products, Medicine
• State: Powder
• Extract Source: S. Baicalensis (Huangqin)
• Name: Oroxylin a
• Appearance: Yellow Powder
• Assay: 98%
• CAS: 480-11-5
• OEM: Available
• Sample: Available
• Suitable: Adult
• Function: Anti-Cancer
• MOQ: 100g
• Transport Package: Foil Bag
• Specification: 98
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Oroxylin A
Appearance	Yellow Powder
CAS NO.	480-11-5
Molecular Formula	C16H12O5
Storage	Keep in a cool, dry, dark location

 

Oroxylin A, also known as Baicalein 6-methyl ether or 6-Methoxybaicalein, is an active flavonoid compound extracted from the plant Scutellaria baicalensis (Huangqin) with a broad range of pharmacological activities.

 

 

1. Pharmaceutical Drug Development: Due to its potent anti-cancer, anti-inflammatory, and neuroprotective properties, Oroxylin A is being investigated for potential use in the development of novel pharmaceutical drugs.
2. Cosmetics and Skin Care: Its antioxidant and anti-aging effects make Oroxylin A a promising ingredient in cosmetic formulations for skin rejuvenation and protection.
3. Health Supplements: As a natural bioactive compound, Oroxylin A is also included in health supplements marketed for promoting overall health and wellness.

1. Anti-Cancer: Oroxylin A exhibits anti-proliferative and apoptotic effects on various cancer cell lines, suggesting its potential role in cancer therapy.
2. Anti-Inflammatory: It modulates inflammatory pathways, reducing inflammation and associated symptoms in a variety of inflammatory conditions.
3. Neuroprotective: By protecting neurons from oxidative stress and other insults, Oroxylin A may play a role in preventing or treating neurodegenerative diseases.